
About
-
The intellectual property assets of Accellta include a portfolio of patents pertaining to novel techniques and products, including:- Pluripotent stem Cell culturing
- Human foreskin-derived feeder cells
- Growth media for feeder-free culturing of hPSC
- Stem Cell expansion in suspension
- Stem Cell culturing as single-cells in bioreactors
- Stem-Cell controlled differentiation
- Medium formulation